Skip to Main Content

Author Details

Runze Shang
Affiliated Haixia Hospital of Huaqiao University (The Hospital)
2014
43
22
PMIDPaper TitleJournal TitlePublished Year
35917112Targeting microbiota-host interactions with resveratrol on cancer: Effects and potential mechanisms of action.Crit Rev Food Sci Nutr2024
35921500Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis.Hepatology2023
36890279Retraction Note: PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612.Oncogene2023
35076948Therapeutic efficacy of FASN inhibition in preclinical models of HCC.Hepatology2022
35841383LOXL3-promoted hepatocellular carcinoma progression via promotion of Snail1/USP4-mediated epithelial-mesenchymal transition.Environ Toxicol2022
35783831Case Report: Tachycardia, Hypoxemia and Shock in a Severely Burned Pediatric Patient.Front Cardiovasc Med2022
35311105Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma.Front Oncol2022
33144318Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma.Gut2021
33542902Silencing of KIF3B Suppresses Breast Cancer Progression by Regulating EMT and Wnt/<i>β</i>-Catenin Signaling.Front Oncol2021
34696683Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.Bioengineered2021
34625531Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma.Cell Death Dis2021
32174012Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.Mol Oncol2020
32031163Combined Use of Three Machine Learning Modeling Methods to Develop a Ten-Gene Signature for the Diagnosis of Ventilator-Associated Pneumonia.Med Sci Monit2020
32019910Oncogene-dependent function of BRG1 in hepatocarcinogenesis.Cell Death Dis2020
32011034Suppression of KIF3A inhibits triple negative breast cancer growth and metastasis by repressing Rb-E2F signaling and epithelial-mesenchymal transition.Cancer Sci2020
32035060mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy.Am J Pathol2020
30444423Circular RNA circRHOT1 is upregulated and promotes cell proliferation and invasion in pancreatic cancer.Epigenomics2019
31411555Dual effects of an anti-CD147 antibody for Esophageal cancer therapy.Cancer Biol Ther2019
31383647SNAI1 Promotes the Cholangiocellular Phenotype, but not Epithelial-Mesenchymal Transition, in a Murine Hepatocellular Carcinoma Model.Cancer Res2019
30742121Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence.Nat Med2019
30741922MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment.Cell Death Dis2019
30737831Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in Mice.Hepatology2019
31062368The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans.Hepatology2019
29618926Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy.Int J Nanomedicine2018
35694125Clinical applications of retinal gene therapies.Precis Clin Med2018
30068940PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612.Oncogene2018
30015982Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.Oncol Rep2018
30545369Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma.Cell Commun Signal2018
29474911Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning.Cell2018
27617908The emerging landscape of circular RNA in life processes.RNA Biol2017
28260073FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.Oncol Rep2017
28081727MicroRNA-200a Suppresses Cell Invasion and Migration by Directly Targeting GAB1 in Hepatocellular Carcinoma.Oncol Res2017
28429769Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors.Cell Res2017
29285255Agrin para-secreted by PDGF-activated human hepatic stellate cells promotes hepatocarcinogenesis <i>in vitro</i> and <i>in vivo</i>.Oncotarget2017
29035356Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.Nat Mater2017
28714366High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes.Tumour Biol2017
26871477MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.Oncotarget2016
26546438RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.Tumour Biol2016
26482611Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer.Tumour Biol2016
28018100Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.World J Gastroenterol2016
27386842Impact of Combination Epidural and General Anesthesia on the Long-Term Survival of Gastric Cancer Patients: A Retrospective Study.Med Sci Monit2016
26052092Circular RNA: A new star of noncoding RNAs.Cancer Lett2015
25337205Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.Int J Clin Exp Pathol2014
  • 1 - 43 of 43

Recommended Authors

Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 0
Meixiao Zhan
Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year 2013
Number of shared co-authors 0
Wei Wang
Shanghai East Hospital, Tongji University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Xiongjun Wang
Guangzhou University
Career Start Year 2013
Number of shared co-authors 0
Hao Tang
Guizhou Medical University
Career Start Year 2013
Number of shared co-authors 0
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Hua Yu
Guangzhou University
Career Start Year 2009
Number of shared co-authors 0
Ligong Lu
Guangdong General Hospital, Guangdong Academy of Medical Sciences
Career Start Year 2007
Number of shared co-authors 1
Liang Liang
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Hae-Yun Jung
College of Life Science, CHA University
Career Start Year 2003
Number of shared co-authors 0
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 0
Li Liu
Nanfang Hospital, Southern Medical University
Career Start Year 2003
Number of shared co-authors 0
Xin Yang
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 0
Qiyu Zhang
The First Affiliated Hospital of Wenzhou Medical University
Career Start Year 2002
Number of shared co-authors 0
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Youn-Jae Kim
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
Feng Zhu
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Na Zhang
Obstetrics and Gynecology Hospital of Fudan University
Career Start Year 1997
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 1
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Xin Wei Wang
Center for Cancer Research, National Cancer Institute (NCI)
Career Start Year 1994
Number of shared co-authors 1
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 1
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 0

Collaborators

Yaou Duan
and Moores Cancer Center, University of California at San Diego
Co-authored papers 5
Kang Zhang
College of Animal Science and Technology, Guangxi University
Co-authored papers 5
Charlotte Zhang
Guangzhou Women and Children's Medical Center, Guangzhou Medical University
Co-authored papers 5
Xin Fu
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Co-authored papers 4
Edward Zhang
and Moores Cancer Center, University of California San Diego
Co-authored papers 4
Rui Hou
Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University
Co-authored papers 4
Jie Zhu
Guangzhou Women and Children's Medical Center, Guangzhou Medical University
Co-authored papers 4
Lianghong Zheng
Guangzhou Youze Biological Pharmaceutical Technology Company Ltd.
Co-authored papers 3
Daniel S Kermany
Guangzhou Women and Children's Medical Center, Guangzhou Medical University
Co-authored papers 3
Ou Li
College of Life Science, Zhejiang Sci-Tech University
Co-authored papers 3
Wenjia Cai
Fifth Medical Center of Chinese, PLA General Hospital
Co-authored papers 2
Sierra Hewett
Stanford University
Co-authored papers 2
William Shi
Institute for Genomic Medicine, University of California
Co-authored papers 2
Viet Anh Nguyen Huu
University of Cambridge
Co-authored papers 2
Xiaodong Sun
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Co-authored papers 2
Cindy Wen
University of California San Diego
Co-authored papers 2
Xiaokang Wu
College of New Energy and Environment, Jilin University
Co-authored papers 2
Huimin Cai
Department of Agricultural College, Guangxi University
Co-authored papers 2
Sally L Baxter
University of California San Diego
Co-authored papers 2
Huiying Liang
Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences
Co-authored papers 2
Huimin Xia
Guangzhou Women and Children's Medical Center, Guangzhou Medical University
Co-authored papers 2
Gen Li
Research Center for Nano-Biomaterials, Sichuan University
Co-authored papers 2
Michael H Goldbaum
University of California San Diego
Co-authored papers 2
Hannah Carter
University of California San Diego
Co-authored papers 2
Hua Shao
Co-authored papers 1
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
Pin Tian
Co-authored papers 1
Qiaozhen Hou
Guangzhou Women and Children's Medical Center, Guangzhou Medical University
Co-authored papers 1
Sarah Gibson
Co-authored papers 1
Yugui Zhou
Guangzhou Women and Children's Medical Center, Guangzhou Medical University
Co-authored papers 1
Release 1.2